Announcements Trials

Browse Landscape

Phase

Phase 2 69 Phase 1 41 Phase 1/2 26 Phase 3 7 Phase EARLY_PHASE1 6 Phase NA 5 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 8 Recurrence 3 Astrocytoma 3 Gliosarcoma 2 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Pituitary Neoplasms 1 Oligodendroglioma 1 Non Small Cell Lung Cancer Metastatic 1 Melanoma 1 Medulloblastoma 1 Glioma 1 Ependymoma 1 Brain Neoplasms 1 Advanced Glioblastoma 1

Interventions

trametinib 1 entrectinib 1 dabrafenib 1 cobimetinib 1 carbon-11 acetate 1 capmatinib 1 Vemurafenib 1 Temozolomide 1 Magnetic Resonance Spectroscopy 1 Lomustine 1 Ga(III)-DOTATOC 1 Disulfiram 1 Copper 1 Carbon-11 1 Alkylating Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Glioma × Temozolomide × Clear all

NCT02678975 2021-03-18

Disulfiram in Recurrent Glioblastoma

Sahlgrenska University Hospital

Phase 2/3 Completed

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡